Exo Honored as a Most Innovative Digital Health Startup of 2021

Exo continues to be recognized as a pioneer in health information and medical imaging with CB Insights recently naming Exo to its Digital Health 150 List of the most promising, private digital health companies in the world. CB Insights develops software that enables digital health companies to manage end-to-end technology to make decision-making processes more efficient.

“This recognition by CB Insights is deeply rewarding as our company continues to reinvent the way physicians use medical imaging technology to triage, diagnose and treat patients at the point-of-care,” said Sandeep Akkaraju, CEO of Exo. “This year, we closed a $220 million Series C investment that will allow us to further our vision of a future healthcare system that’s unconstrained by the four walls of a hospital.”

In 2022, Exo will deliver a medical imaging ecosystem that includes high performance ultrasound technology that will empower health care professionals to see clearly into every body for real time decision-making and an intuitive ultrasound workflow solution that works with nearly every point-of-care ultrasound device and the most common EMR and PACS.

Exo Works solves decades-long workflow challenges by streamlining exam review, documentation, billing and quality assurance management all in one platform – in seconds.

Exo’s inclusion as a top digital health startup company was unveiled at the CB Insights Future of Health virtual conference in December 2021. The CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies; Exo was chosen based on several factors, including data submitted, business models and momentum in the market. “This year’s Digital Health 150 is one of our most expansive yet, spotlighting 16 categories including virtual care, clinical trials tech, and workflow automation, as well as adding new categories such as home health tech and computer-aided imaging,” said Brian Lee, SVP of CB Insights’ Intelligence Unit.

The 2021 Digital Health 150 cohort raised roughly $14.9 billion dollars in aggregate funding across 522 deals since 2016, and includes startups at various investment stages of development, from early-stage to well-funded unicorns; these are startup companies that value over $1 million dollars.

Last year`s cohort raised an additional $18.6 billion in aggregate funding and announced more than 250 partnerships since being recognized. The complete Digital Health 150 List can be found here.

To stay in the know with updates on everything Exo, including the latest on the handheld imaging device, sign up for the newsletter.

2021 Digital Health 150 Investment Highlights:

• Unicorns: 17 of the 150 companies (11%) are valued at or above $1B as of their latest funding rounds.
• Funding trends: In 2021 year-to-date (YTD), these 150 private companies have raised $9.2B in equity funding across 153 deals (as of 11/19/21).
• Mega-rounds: Since 2020, there have been 39 mega-round ($100M+) equity investments to this year’s Digital Health 150, with 31 (79%) of them taking place in 2021 YTD.
• Global representation: 23% of the 2021 Digital Health 150 are based outside the US. After the US, the UK is home to the most Digital Health 150 companies (9), followed by India (4). This year’s winners are based in 18 countries, including China, Israel, Nigeria, Germany, Argentina, and New Zealand.